Earnings dates and session timing shown here are aggregated from third-party sources, are frequently estimated, and are subject to change or confirmation by the reporting company. Nothing on this site is financial advice.
Cytek Biosciences Inc (CTKB) is a pioneering force in multi-parameter flow cytometry, delivering innovative cell analysis solutions that advance research in immunology, cancer diagnostics, and drug development. The company leverages its proprietary technologies to meet the growing demand for precision in cellular analytics, positioning itself as a key player in the biotechnology sector. With a robust product portfolio and a commitment to exceptional customer support, Cytek is well-equipped to drive transformative discoveries, ultimately enhancing healthcare outcomes and addressing critical challenges in the life sciences.
Quotes and fundamental data are delayed and provided for informational purposes only — nothing on this page is financial advice. Figures are as reported by the company and its data providers and may be revised. Estimates reflect analyst consensus at the time of each report.
$4.61
| Quarter | EPS | Revenue | Price move | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Est | Adj | Result | GAAP | Est | Actual | Surprise | 1D Pre | On-Day | 1D Post | |
Q ended Jun 30, 2026 Reported Aug 5, 2026 | $-0.06 | $-0.09 | Miss -50.0% | — | $48.61M | $48.14M | -1.0% | 1D Pre-0.7% | On-Day-2.3% | 1D Post-0.5% |
Q ended Mar 31, 2026 Reported May 7, 2026 | $-0.08 | $-0.10 | Miss -25.0% | — | $44.3M | $44.13M | -0.4% | 1D Pre+3.3% | On-Day-0.4% | 1D Post-6.3% |
Q ended Dec 31, 2025 Reported Feb 26, 2026 | $-0.04 | $-0.04 | ||||||||
Dashed outlines show the analyst consensus estimate for periods where one was published. Hover or tap a bar for exact figures. Values as reported; not adjusted for splits after the report date.
| Met 0.0% |
| — |
| $58.8M |
| $62.14M |
| +5.7% |
| 1D Pre+0.2% |
| On-Day+0.7% |
| 1D Post+1.8% |
Q ended Sep 30, 2025 Reported Nov 5, 2025 | $-0.05 | $-0.04 | Beat +20.0% | — | $51.14M | $52.29M | +2.2% | 1D Pre-0.8% | On-Day+2.6% | 1D Post+13.2% |